CClinicalTrials.gg
CompletedNCT05111106Updated Nov 8, 2021

Symfony Intraocular Lens Retrospective Chart Review

An observational study in Cataract, sponsored by Austin Eye. Completed. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-11-08.

Sponsored by Austin Eye · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
463
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Retrospective chart review of patients with pre-existing ocular pathology who underwent cataract surgery with implantation of the Symfony IOL.

Read the detailed description

This was a retrospective chart review conducted at a single US clinical site. Chart review was conducted by John Odette, MD and research assistants. Eligible charts were identified via a clinic database search of cataract surgeries with IOL implantation of the Symfony IOL during the stated date range. Eligible charts included those of patients 18 to 90 years of age who underwent Femto Laser Assisted Cataract Surgery (FLACS) with implantation of a Symfony IOL. Charts were excluded for lack of postoperative follow-up or if Symfony IOL was not implanted. All qualifying patient charts were examined and further classified into 2 groups: (1) eyes with glaucoma; and 2) eyes without glaucoma. Visual acuity was evaluated for patients who underwent cataract surgery with implantation of the Symfony IOL from 09/1/2016 to 05/31/2018. Postoperative evaluations at Month 2 included mean monocular uncorrected visual acuity at near (UNVA) at 40 cm, far distance (UDVA) at 20 ft, and with best correction (CDVA). Outcomes were also compared for toric IOLs versus spherical IOL.

02

Conditions studied

  • Cataract

Browse trials for

Keywords

  • Cataract surgery
  • Glaucoma
  • Retinopathy
  • Intraocular Lens
03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 463 is above the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

This is the only study on the registry with Austin Eye as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients (18-90 years old) in need of cataract surgery.

Inclusion criteria

  • :Phacoemulsification cataract surgery with a Symfony IOL.

Exclusion criteria

Exclusion Criteria:

  • : Eyes not implanted with a Symfony IOL or unstable refractive results at final post-operative visit
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
463 participants (actual)
Patient registry
No

Groups and cohorts

  • Non-Pathology Eyes

    Cataract Surgery with implantation of Symfony IOL in eyes without pre-existing pathology..

    Device: Symfony IOL

  • Glaucoma Eyes

    Cataract Surgery with implantation of Symfony IOL with pre-existing glaucoma.

    Device: Symfony IOL

  • Retinopathy Eyes

    Cataract Surgery with implantation of Symfony IOL in eyes with pre-existing retinal pathology..

    Device: Symfony IOL

Interventions

  • DeviceSymfony IOL

    Implantation of Intraocular lens with extended depth of focus.

06

What researchers measure

Primary outcomes

  1. Monocular uncorrected near visual acuity

    handheld near card (Jaeger scale)

    Time frame: 2 months

Secondary outcomes

  1. Monocular best corrected distance visual acuity

    Snellen Chart at 20 feet

    Time frame: 2 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05111106
Lead sponsor
Austin Eye
Collaborators
Johnson & Johnson
Responsible party
John Odette (John Odette, MD, Austin Eye) — Principal investigator
First posted
Nov 8, 2021
Start date
Oct 5, 2016
Primary completion
Dec 31, 2018
Completion
Dec 31, 2018
Last update
Nov 8, 2021

Study contacts

John Odette
principal investigator · Austin Eye Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion